DUBLIN, Sept. 19, 2022 /PRNewswire/ — The “Growth Opportunities in Military Medical Device Technologies” report has been added to ResearchAndMarkets.com’s offering.
This research service examines the emerging technologies being used in military health systems.
This study covers only locally applied hemostatic agents in prehospital settings; intravenous infusion in hospital settings is not included.
In addition to hemostatic wound care, the use of health monitoring devices such as wearables is growing. These devices track vital statistics, including heart rate, blood pressure, and stress and fatigue levels and also enable decision-making pertaining to medical evacuation. Digital health technology is also being used for proactive wellness care and to take care of the mental health of personnel.
Over the years, the healthcare industry has developed several unique technologies for emergency medical services and critical care. An important user of critical care healthcare products is the military or the defense forces. Advanced medical technologies have improved the care that is offered, and they also enable safer and quicker care for soldiers.
Severe hemorrhages can result in hemodynamic instability, hypoxemia, multiple organ failure, or death. A key reason for patient fatality is blood loss due to trauma or injury on the battlefield. Typically, intravenous (systemic) or local (topical) hemostatic agents are used to control excessive bleeding.
Natural biomaterials have gained popularity due to their ease of use and rapid action. However, some of these hemostatic dressings cause irritation and exothermic reactions on the skin and take slow action to stop the bleeding. Advanced hemostatic wound care solutions address these challenges, and they will play an important role in military health systems.
The augmented and improved performance of human beings with enhanced physical power and immunological resistance will become important future expectations on the battlefield. Human augmentation devices such as exoskeletons will revolutionize the military health system through the prevention of injuries.
Key Topics Covered:
1. Strategic Imperatives
Why Is It Increasingly Difficult to Grow? The Strategic Imperative: Factors Creating Pressure on Growth
The Strategic Imperative
The Impact of the Top 3 Strategic Imperatives on the Military Medical Device Industry
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Environment Analysis
Rapid Care and Mobile Care are the Key Military Health System Requirements.
Digital and Robotic Technologies are Addressing Military Health Requirements.
The Key Innovation Areas in Military Health Systems Include Wound Care, Health Monitoring, and Human Augmentation.
Increased Funding and Collaboration between MedTech and Federal Organizations are Driving Technology Advancements.
Cybersecurity and Connectivity Concerns are Challenging the Adoption of Digital Health Devices.
Scope of Analysis
3. Hemostatic Innovations for Militaries
Hemostatic Solutions in Militaries – Key Requirements
Bandages and Gauze Embedded with Hemostatic Materials are the Most Commonly Used Hemostatic Products.
Emerging Hemostasis Technologies and Trends in Military Settings
Hemostatic Biomaterials from Natural Sources
Universities’ Noteworthy Hemostatic Innovations
Emerging Hemostatic Innovations to Address Truncal Hemorrhages
Chitosan-based Wound Dressings for Hemostatic Effect
Kaolin-based Hemostatic Dressings that Accelerate the Body’s Natural Clotting Process
Chitosan-based Wound Dressings for Bleeding Control
All-in-One Pressure Bandages that Stop the Bleeding of Severe Wounds
4. Wearable Health Monitoring Innovations for Militaries
The Monitoring of Military Personnel Health Enables Better Physical and Mental Health and Reduces Injuries.
Wearables are the Most Commonly Used Technology Platforms for Remote Health Monitoring in Militaries.
Emerging Technologies and Trends in Wearable Health Monitoring for Militaries
Sensor and Digital Innovation in Health Monitoring
Universities’ Noteworthy Remote Health Monitoring Innovations
Remote Health Monitoring of Soldiers’ Physiological and Behavioral Data
Mobile Health Application to Monitor Users’ Moods and Emotions
Tissue-integrated Biosensors for the Continuous Monitoring of Body Vitals
Smartphone-compatible Application for the Early Detection of Injuries
5. Robotic Exoskeleton Innovations for Militaries
Robotic Exoskeletons Reduce the Risk of Injury in Military Personnel.
Innovations in Materials, Actuators, and Power to Improve the Performance of Robotic Exoskeletons
Universities’ Noteworthy Soft and Lightweight Robotic Exoskeleton Innovations
Smart Exoskeletons Capture Crucial Insights about Soldiers.
Load-bearing Exoskeletons to Improve Performance and Reduce Musculoskeletal Injuries
Full-body Exoskeleton Suits to Improve Physical Strength
Smart Exoskeletons to Improve Endurance and Provide Unimpaired Mobility
Human Biomechanics-inspired Exoskeleton Suits to Improve Operator Mobility
6. Innovation Indicators
Military-funded Research is Driving Innovation in Hemostatics.
A Growing Number of Partnerships will Provide More Efficient Wound Care Solutions in Military Settings.
Private and Public Funding is Accelerating the Development of Innovative Wound Care Products.
Government-led Efforts are Encouraging Innovation in the Exoskeleton Industry for Defense.
Collaborations and Partnerships will Expand the Use of Robotic Exoskeletons in Defense.
The US Military is Actively Adopting Real-time Monitoring to Control its Troops.
The US Military is Partnering with Digital Health Technology Companies to Optimize Soldiers’ Performance.
US and Chinese Defense Bodies are Adopting Emerging Technologies in Military Health, Especially Digital Technologies.
The Russian Military is Focusing on Human Augmentation Technologies.
Smart Garments and Robotic Exoskeletons are the Most Impactful Emerging Medical Technologies in Military Health Systems.
Hemostatic and Health Monitoring are Easy-to-Implement and Highly Impactful Solutions that Improve the Health of Military Personnel.
Technology Roadmap of Military Medical Systems
7. Growth Opportunity Universe
Growth Opportunity 1: Easy-to-Use and Quick Wound Sealing Hemostatic Solutions for Trauma Injuries
Growth Opportunity 2: Digital Behavioral Therapy for Military Personnel
Growth Opportunity 3: Patient-centric Care for Military Personnel
For more information about this report visit https://www.researchandmarkets.com/r/wq5cyk
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-military-medical-device-technology-analysisopportunity-report-2022—rapid-hemostasis-health-monitoring-wearables-and-human-augmentation-are-improving-the-health-of-the-armed-forces-301626980.html
SOURCE Research and Markets
The FDA approved Heron Therapeutics Inc's (NASDAQ: HRTX) Aponvie (aprepitant) injectable emulsion for intravenous use for the prevention of postoperative nausea and vomiting (PONV) in adults. Aponvie is the first and only IV formulation of aprepitant for PONV prevention. Aponvie is provided in a single-dose vial that delivers the full 32 mg dose approved for PONV. The ready-to-use, easy-to-administer, innovative IV formulation ensures rapid and consistent exposure in surgery patients. Related: H
Yahoo Finance's Julie Hyman discusses the reversal in Bluebird Bio shares after the FDA approved its second gene therapy.
It’s been more than 2.5 years and Americans are still suffering from the long-term effects of COVID-19, otherwise known as Long COVID, and it's forced many out of the labor force.
Undaunted by a potential battle with a goliath like Pfizer, Prometheus is developing PRA023, an experimental treatment for inflammatory bowel disease. Prometheus' candidate could eventually generate billions in annual revenue, but it will have to overcome PF-06480605, a similar candidate from Pfizer. Can Prometheus take on Pfizer in the lucrative space for inflammatory bowel disease treatments?
What happened Shares of Moderna (NASDAQ: MRNA) fell 7% on Monday, following President Joe Biden's interview on 60 Minutes on Sunday. So what President Biden's comments on the state of the COVID-19 pandemic clearly caught the attention of investors.
Few daily rituals hold quite as much importance as brushing your teeth. Besides being a grooming requirement essential for keeping your breath fresh, research has also shown that it can have a significant impact on your long-term health as well. In most cases, the only harm that can come from picking up your toothbrush is the result of doing something wrong during the twice-a-day cleaning ritual. But now, the Food&Drug Administration (FDA) is warning that anyone with certain Colgate toothpastes
Intellia Therapeutics (NTLA) reported positive interim results for its CRISPR candidates being evaluated to treat transthyretin (ATTR) amyloidosis and treating hereditary angioedema (HAE).
CHMP recommends authorizing AstraZeneca's (AZN) Evusheld as a COVID-19 treatment and its RSV vaccine, nirsevimab in Europe.
Ukrainian forces said they now control the eastern bank of the Oskil River in the Kharkiv region, while Russia continues to launch attacks against civilian infrastructure in Ukraine following its military setbacks in the country’s east.
Moscow is in a downward spiral of mounting defeats – both military and diplomatic ones – as international relations expert Ivan Yakovyna explains in his Sept. 16 NV Radio program.
OLENA ROSHCHINA – MONDAY, 19 SEPTEMBER 2022, 21:17 The Special Operations Forces (SOF) of the Armed Forces of Ukraine have shown a video, in which they destroyed a Russian observation post on the Bakhmut front.
Gilead's (GILD) COVID-19 treatment Veklury and CAR T-cell therapy Yescarta get positive CHMP recommendation for additional indications.
One of Russian President Vladimir Putin's top allies said on Tuesday he favoured holding referendums in two eastern Ukrainian regions in order to formally make them part of Russia, a move that would seriously escalate Moscow's confrontation with the West. The statement by Dmitry Medvedev, a former president who is currently deputy chairman of the Security Council, marks a hardening of Russian rhetoric on Ukraine and is the strongest sign yet that the Kremlin is considering going ahead with a plan that Ukraine and the West have said would be illegal. He made his comments as Putin ponders his next steps in a nearly seven-month-old conflict that has triggered the biggest confrontation with the West since the 1962 Cuban Missile Crisis and after a battlefield defeat in northeast Ukraine.
Ukraine recaptures first village in Luhansk More military defeats could ‘finish off Putin’ Russia strikes major nuclear power plant For more insight into the war latest to our podcast
OLHA HLUSHCHENKO – TUESDAY, 20 SEPTEMBER 2022, 07:43 The General Staff of the Armed Forces of Ukraine reports that Russian occupiers have revoked the deferment of mobilisation for around 500 workers of the Yenakiieve Iron and Steel Works, in the Russian-occupied city of Yenakiieve in Donetsk Oblast.
Ukraine is now deploying captured Russian tanks to solidify its gains in the northeast amid an ongoing counteroffensive, a Washington-based think tank said Tuesday, as Kyiv vowed to push further into territories occupied by Moscow. The Institute for the Study of War, citing a Russian claim, said that Ukraine had been using left-behind Russian T-72 tanks as it tries to push into the Russian-occupied region of Luhansk. “The initial panic of the counteroffensive led Russian troops to abandon higher-quality equipment in working order, rather than the more damaged equipment left behind by Russian forces retreating from Kyiv in April, further indicating the severity of the Russian rout,” the institute said.
OLHA HLUSHCHENKO – TUESDAY, 20 SEPTEMBER 2022, 02:30 The Armed Forces of Ukraine have struck several areas where Russian forces were concentrated in Southern Ukraine, killing 90 Russian soldiers and destroying their military equipment.
US Health Sec. Xavier Becerra doubled down on off-the-cuff remarks from President Joe Biden that the pandemic is over in the country.
By Rachael Green, Benzinga
(Bloomberg) — Bluebird Bio Inc.’s shares fell Monday after US regulators approved its gene therapy for a brain-wasting disease with a warning about cancer risks and under the condition that the drugmaker can show that it works long term.Most Read from BloombergSouthwest Mexico Struck by 7.5 Magnitude Earthquake, Buildings Sway in CapitalHome-Flipper Opendoor Hit With Losses in Echo of Zillow CollapseMark Zuckerberg’s $71 Billion Wealth Wipeout Puts Focus on Meta’s WoesGrand Theft Auto VI Leak I